Meeting Summary of May Networking Event

On May 18, the GLSA and FOCM held their monthly online networking event. We always start the meeting with some time for people to give an update on any news they’re heard or a significant event that has happened in the past month. Then we move to a featured presenter for 10 – 15 minutes presenting information about themselves, their company or a clinical research topic of relevance to them or to the industry.

This event featured Alison Macpherson, CEO and Founder of Bright Pharmaceutical Services, a full service CRO headquartered in Los Angeles.  Bright is celebrating their 20th year in business.
http://www.brightps.com/

Alison talked about her experiences starting out in the clinical trials industry and how that led to her forming Bright with a boutique sponsor-centric approach and a focus on subject recruitment and retention. The company has worked in a variety of therapeutic areas and all phases of research.  Its differentiators from other similar sized CRO’s is the very low turnover (less than 5%) over the 20 years in business, which means clients’ projects are supported by only very experienced and engaged staff. Additionally, while much of their experience is in phase I and II North America trials, they have worked in 30+ countries globally.  Questions were handled as they came up leading to discussions about Bright’s experience with risk-based monitoring; the new normal of hybrid and decentralized trials; reducing the frequency of subject visits to the sites; and Bright’s experience with trials that require collecting data from wireless, connected devices, e-source data, etc.

After the presentation we had first time participants share their company names and experience. Josh Lang, Mike O’Gorman and Denise McNerney will be attending BIO in San Diego June 13 – 16.  Carlos mentioned the networking event they are having on June 12 in San Diego for people interested in Farmacon Global’s August 25 conference focused on conducting clinical trials in Rare Diseases in Emerging Markets.In posing this question to the group – what are you working on and what do you need help with, Heather Hollick (who taught me this approach for successful networking) mentioned she is starting the Institute for Vibrant Leadership and could use connections to leaders, coaches with whom to collaborate as well as writers and virtual assistants. Subsequently, a few potential connection candidates have been sent to her. https://heatherhollick.com/

Attendees (bolded names indicate first time attendees):

Alison Macpherson, Bright Pharma Services
Heather Hollick, Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Nicole O’Brien, Pain Care Labs
Josh Lang, Asymchem Group
Barbara Hilewsky, BRCR Global
Shane Krauss, Strados Labs
Carlos Martinez, Farmacon Global
David Holland, Cmed Research
Michael O’Gorman, Life Science Marketplace
Keisha Felix, IQVIA
Ludmilla Scodeler
Jim Choi, CRScube
Cesar Serapiao
Chris Matheus, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance
Denise McNerney, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance
Todd Neilson, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance

Several screen shots follow:

Bright Pharma Services

 

Screenshot of May 18 2022 event
Screen shot of May 18 2022 event

 

 

April 20 Networking Event Summary

On April 20, the GLSA and FOCM held their monthly online networking event. We always start the meeting with a featured presenter spending 10 – 15 minutes presenting information about themselves and a clinical research topic of relevance to them or to the industry.

This event featured Amy Baxter, MD; CEO and Founder of Pain Care Labs. PCL’s NIH-funded pain relief device is an ingenious intervention to reduce needle pain and fear.   https://paincarelabs.com/

Amy presented information on research results showing the incidence of needle fear among Americans. Research shows that 25% of Americans are adverse to needles. This is playing a role in the slower than desired vaccination rates against COVID-19.

Needle fear has increased dramatically since 1995 when it was reported that 10% of adults and 25% of children feared needles. Prior to 1980, children’s last vaccination was at age 2, except for DPT boosters every 10 years. Since 1980, children receive booster injections between the ages of 4 and 6, when fears form. A study in 2012 from Canada shows 63% of people born after 2012 have needle phobia. 

Pain Care Labs has developed Buzzy for the management of needle phobia. This combines the distraction of cold with deep vibration which blocks the pain signal. Managing needle phobia is important for increasing vaccination rates among people of all ages. It can also play a role in clinical research if a clinical trial is a vaccine trial or a protocol requiring multiple needle-sticks, Such trials may have higher drop-out rates or decline to enroll due to the subjects’ fear. 

After the presentation, there were questions, answers and discussions.  We then allowed newer participants the opportunity to tell us about their history in the industry and ask how the group can be of help. Additionally, after the event Heather Hollick shared observations about what makes the GLSA online networking events work so well is: 

  • Starting with initial casual conversation
  • Having a 15-20 minute learning session
  • Breaking into groups of 2-4 people several times so all can meet each other and share what they’re working on
  • Ending with closing remarks, comments and observations. 
  • Online networking requires light moderation, because we’re missing body language for our cue as to who is to speak next. 

Amy provided a good suggestion that we start these with a general ice breaker, a question or topic each can respond to. We’ll begin implementing that for our July event. The July and August events will be light-hearted and casual, imagine sipping a cocktail on a beachside outdoor deck with friends. In September, we’ll return to focused topics/presentations after the general ice breaker and before break out networking.

Attendees (bolded names indicate first time attendees):
Amy Baxter, MD; Pain Care Labs
Nicole O’Brien; Pain Care Labs
Peter Payne; Consultant
David Rodrin; IMA Clinical Research
Daniel Paszterko; Myonex
Ari Cofini; VeriSIM Life
Neil Banerjee; QMS Integrity
Nancy Zeleniak; Atrium Health
Mike Minor; IMA Clinical Research
Brittany Barber, Syneos Health
Nicole Aubrey; Aubrey Cole Consulting
Maria Frane, Simbec-Orion
Ravipal Luthra, University of Miami, Miller School of Medicine
Heather Hollick, Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Mike O’Gorman, Life Science Marketplace
Edwin Gershom, Noble Life Sciences
Hannah Lloyd, Global Life Sciences Alliance
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

Screenshots from the event:

Screenshot with Teddy in center square
Amy Baxter, MD; CEO & Founder of Pain Care Labs
Needle Fear Statistics
Buzzy for needle pain
Screenshot of Attendees
Screenshot of Attendees

March Networking Event Summary

On March 16, the GLSA and FOCM held their monthly online networking event.  We start the meeting with a featured presenter spending 10 – 15 minutes presenting information about themselves and a clinical research topic of relevance to them.

This event featured Wessam Sonbol, founder of Delve Health. Wessam has been in the clinical research industry for 23 years. Many of these years have been in leadership and founding roles in the technology and product development to facilitate trials. He founded Delve Health in 2018.  Delve Health provides innovative decentralized clinical trial solutions to improve clinical trial conduct for patients, caregivers, doctors and pharma/device. Offerings include ePRO/eCOA, eConsent, study tasks, wearables and biosensor integration, EMR data collection and Real-world evidence capabilities.

After the presentation, there were questions, answers and discussions.  We then allowed newer participants the opportunity to tell us about their history in the industry and the group can be of help.

Attendees (bolded names indicate first time attendees):
Wessam Sonbol, Delve Health
Andrew Mulchinski, Symbio Research
Ravipal Luthra, University of Miami, Miller School of Medicine
Heather Hollick, Rizers LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Michael Young, biomedwoRx: Life Sciences Consulting
Mike O’Gorman, Life Science Marketplace
Edwin Gershom, Noble Life Sciences
Taylor Biche, Global Life Sciences Alliance
Holly Cliffe, Global Life Sciences Alliance
Todd Neilson, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

https://globallifesciencesalliance.com/

Please join us on April 20 where the featured presenter will be Amy Baxter, MD; CEO and Founder of Pain Care Labs. PCL’s NIH-funded pain relief device is an ingenious intervention to reduce needle pain and fear – improving patient participation in clinical trials.

Selected screen shots appear below:

Delve Health Presenting
Screenshot #1
Screen shot #3
Screenshot with Teddy in lower left
Screenshot #2

 

 

February Networking Event Summary

 

On February 16, 2022, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was the second event of 2022 and like the January event, we again had 3 first-time attendees. Thank you to super-connector and FOCM member, Nadia Bracken for sharing our event with others.

We spent the first 15 minutes with introductions and general discussion about the weather in various attendees’ cities.  

This event featured a presentation by Kalyan Ghosh, Founder and CEO of Inference, Inc (https://inferenceinc.com/).  Inference, a GLSA client, was formed in 2017 by Kalyan.  He has over 25 years experience in clinical biostatistics, having worked at both big pharma (Merck and BMS) and CROs (Vislation, INC Research and West Coast Clinical Trials). Kalyan is an accomplished presenter and presented an overview of biostatistics and the role that data management and biostatistics have in drug development. 

Please join us next month on March 16 at 7:00 p.m.  Wessam Sonbol, CEO of Delve Health, an e-clinical technology platform service provider and client of GLSA will spend 10 – 15 minutes talking about their approach to patient-centered hybrid and decentralized studies in drug development.

ATTENDEES (bolded names were first time attendees):

Kalyan Ghosh, Inference Inc,
Andy Mulchinski, Symbio
Justin Gundelach, Mayo Clinic
Pauline Luong, Creative Clinical R & D
Chris Bergey, NaviDx
Brian Langin, Matrix Medical
Ravipal Luthra, University of Miami College of Medicine
Jon Matheus,  A.T. Pancrazi Real Estate Services, Inc.
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Holly Cliffe, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance
Todd Nielson, Global Life Sciences Alliance

Screenshots of the attendees can be seen here: https://globallifesciencesalliance.com/february-networking-meeting-summary/

 

 

 

January Networking Meeting Summary

On January 19, 2022, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was the first event of the new year and we had 3 first-time attendees.  

We kept everyone in one main room and went around the room having each person introduce themselves.  There was an open dialog and discussion on a variety of topics: expectations for COVID cases and treatments, the impact on travel and conventions/conferences and hopes for it to lessen and burn out and become similar to seasonal flu. The concern for another variant that could put us into strict measures is real yet the thought of having to deal with that makes us tired.

Heal Mary, (https://healmaryapp.com/) a GLSA client is an oncology patient recruitment platform founded by Cassandra Hui. Cass is from the tech industry and she started Heal Mary driven by her personal story: “My mom was told to go home and get her affairs in order, that there were no other options… I’ve made it my mission to ensure that patients know ALL of their options.” We showed a video of Cass explaining the motivation for starting Heal Mary using her tech and Artificial Intelligence skills to make sure patients know of treatment options available via clinical trials. https://www.youtube.com/channel/UCLB_CmGY3-trX3rKePF0FWw

Please join us next month on February 16.  Kalyan Ghosh of Inference, a data management  and biostatistics service provider and client of GLSA will spend 10 minutes talking about the role of data management and biostatistics in drug development.

ATTENDEES (bolded names were first time attendees):

Heather Hollick, Rizers, LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Mike Burrows, Burrows Life Science Associates
Kate Findlen, Life Molecular Imaging
Kimberly Lupo, Portrett Pharmaceuticals
Mike O’Gorman, Life Science Marketplace
Andy Mulchinski, Symbio
Brian Langin, Matrix Medical
Charlie Speno, Matrix Medical
Michael W. Young, biomedwoRx: Life Sciences Consulting
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Holly  Cliffe, Global Life Sciences Alliance
Hannah Lloyd, Global Life Sciences Alliance

Screenshots of the event follow:

Screen Shots

Virtual Networking Meeting Summary

On December 15, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event. This was our year-end event and we didn’t have a speaker, topic or theme.

We kept everyone in one room and went around the room asking people to answer a variety of questions. We asked for each person to share what positive or memorable thing happened in 2021 and what they were looking forward to happening in 2022.

  • A representative answer was that while some had caught COVID and it was a bad illness, no one had anyone in their families get severely ill or pass away from it. The outlook for 2022 was felt to be somewhat tentative with the global rise of infections due to the Omicron variant. It was noted that the annual January JP Morgan conference will be virtual again due to the rise in cases. (Occurring today, December 22, Pfizer’s oral dose anti-viral pill to treat COVID was approved.)
  • Michael Young shared that 2021 found him becoming a grandfather with the birth of grandson Oliver Kiesing Miller (pictures below attendee listing). Michael’s hopes for 2022 include completing the first draft of a book he’s writing on “Branding”. He also echoed the feelings of many of us – having the opportunity to see clients, customers and friends in person and a return to in-person conferences. (I think this is the equivalent of a blood transfusion for extroverts).
  • Ires Alliston shared that she is hosting a Female Expert Coaches Summit May 9 – 11 in Daytona Beach, FL. More information is available here: (https://femceosummit.com/).

Movies/TV shows people are watching/recommending:

  • You
  • The Unforgiveable
  • Get Back
  • Curb Your Enthusiasm
  • Giri/Haji
  • Yellowstone

Fountain pens
It turns out that Nadia Bracken has found the hobby of collecting fountain pens. Someone else on the call mentioned a former boss who also did so.  There was a discussion about the psychological draw toward collecting such pens.  I subsequently found this discussion group (https://www.fountainpennetwork.com/forum/topic/136590-pen-personality/) .The hobby appears to be more associated with introversion based on the non-controlled survey in the discussion group. Another article on the topic is: https://www.inkedhappiness.com/fountain-pen-collecting-the-psychology-behind-my-madness/

Toward the end of the event, two things occurred after some had dropped off:

  • Dan Weddle sang and played his guitar
  • Michael Young arrived and showed pictures of his adorable 1st grandson

Please join us next month on January 19

ATTENDEES (bolded names were first time attendees):
Kevin Boos, Rho
Brian Horan, SupplyRx
Wessam Sonbol, Delve Health
Michael W. Young, biomedwoRx: Life Sciences Consulting
Ires Alliston, Business Coach, Consulting & Marketing
Chris Bergey, Humphries Insurance Agency
Nadia Bracken, Medidata
Dan Weddle, AltaSciences
Mike O’Gorman, Life Science Marketplace
Patrick Champoux, SkillPad
Maria Frane, Simbec-Orion
Sara Tylosky, Farmacon
Brennan Munley, Rho
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

Photo Collection

Esteemed Industry Professionals
Revered Industry Professionals
Heralded clinical research industry professionals
Dan Weddle performing an original song
Denise, Zulma and Michael concluding the meeting
Oliver Kiesing Miller, grandson of Michael Young
Oliver Kiesing Miller, grandson of Michael Young

 

November 17 Networking Event Summary

One of the things I thoroughly enjoy about networking is meeting such interesting, fascinating people with different perspectives. This helps us understand and appreciate those differences and helps us re-consider our approach to certain things.

On November 17, the Global Life Sciences Alliance along with FOCM Networking held its monthly online drug and medical device development industry networking event.

Whereas last month we had a featured speaker – Heather Hollick on LinkedIn best practices; this time we just had general discussion and greeting of one another. While there were still a manageable number, I introduced each person and how I know them. There was also discussion and general agreement that when Merck and Pfizer get their oral dose antiviral medicines approved (whether emergency authorization or full approval); the COVID-19 pandemic will become very manageable and the world can return to our new normal; forever impacted but less restricted. (added since the 11/17 meeting – the identification of the Omicron variant may put a slow down on the return; however, early information indicates that while it’s easily transmissible, the symptoms are different and mild, such that as of Nov 30 in South Africa hospital where the doctor found the Omicron variant, no hospitalizations are attributed to it. And now just today, an FDA Advisory panel recommended approval for Merck’s anti-viral pill to treat COVID-19 and reduce hospitalizations.)

We then moved to the evening’s agenda. We had three rooms for people to go to depending on their interests.  The three discussion topics were:

  • Clinical Trial Recruitment and Retention
  • Innovation and Technology
  • Networking

Heather Hollick chaired the Networking room. One discussion centered around how sales/business development people use it and consultant/subject matter experts use it to best fill their connection needs. Interestingly, several participants shared that they control their LinkedIn outreach and purposefully limit their contacts to a more easily managed subset (~1000) to maximize the depth of relationships. Several other participants use a more liberal approach and have grown their networks to over 10,000 contacts who then serve as “private wikis” allowing rapid access to large groups of professionals with multi-various experiences.

Please join us next month on December 15 and if you have a Christmas sweater – wear it!

ATTENDEES (bolded names were first time attendees, I think):

Heather Hollick, Rizers, LLC; Author of “Helpful, A guide to life, careers and the art of networking”
Mike Burrows, Burrows Life Science Associates, LLC
Lacey Clements, IMA Clinical Research
Kevin Boos, Rho
Valerie Roussin-Paradis, SkillPad
Edwin Gershom, Noble Life Sciences
Wessam Sonbol, Delve Health
Michael W. Young, biomedwoRx: Life Sciences Consulting
Nicole Yoon, Mediaiplus
Ires Alliston, Business Coach, Consulting & Marketing
Lindsey Summers, Green Key Resources
Chris Matheus, Global Life Sciences Alliance & FOCM
Denise McNerney, Global Life Sciences Alliance
Joe Buser, Global Life Sciences Alliance
Brandon Huffman, Global Life Sciences Allianc
Holly Cliffe, Global Life Sciences Alliance
Zulma Varela, Global Life Sciences Alliance
Sally Haller, Global Life Sciences Alliance

November 17 2021 Networking Event
November Event Flyer

Meeting Summary of FOCM & GLSA Event

So, it finally happened, on that glorious day which shall long be remembered, these minutes will be heretofore submitted to the USA Library of Congress, the Smithsonian Institute and for reasons unknown, to the Sydney Opera House on the northside bulletin board for public postings.

On May the 20, in the year 2021 of the Gregorian calendar, it was noted that the GLSA (Global Life Sciences Alliance) and FOCM (Friends of Chris Matheus) Networking organization did hold an online (virtual) networking event. The meticulously planned event went terribly awry when but half of the positive RSVPs failed to show up.  That said, it was a resounding success for the initial such event.  A total of 22 attended.

The meeting started off with an acknowledgement that it was Global Clinical Trials Day and a toast was given to the clinical research industry for saving the world from Covid-19 and to James Lind, the Scottish doctor who initiated the first controlled randomized clinical trial on May 20, 1747 aboard a sailing ship. Dr. Lind divided twelve sailors sick with scurvy into six groups of two. They all received the same diet but, in addition, each group was given a different treatment. Only the two sailors who received citrus fruits improved and returned to work.

Chris then introduced the GLSA members to the FOCM community.  After a bit of general discussion, several polls were taken. About half of the group is reluctant to resume conference travel immediately, preferring to wait a few more months. Slightly more than half have been vaccinated or acquired immunity through catching the virus. An interesting opinion was voiced that perhaps as members of the clinical research industry, we should set the example by all being vaccinated.  I, for one and I believe I speak for many of the others have the utmost confidence that not a step was missed, not a shortcut taken in the development of the available vaccines.  Given the prioritization and urgency of vaccine development, we were able to speed up the data review process. The one thing that the sped up development lacked is longer term safety and side effect data.  However, vaccine side effects rarely (I can’t think of any) change the longer from the time of injection.

Then it was time for speed networking!  The assertion has been made by Chris that each of us in the clinical research industry are within 2 degrees of separation from each other. We had 4 different sessions.  Attendees were randomly put into different “rooms” with the assignment to each introduce themselves to the group, sharing where they’d worked the previous 10-20 years and what they’re doing now to see if they could identify who they knew in common.  Good information was exchanged and several new connections were made which can improve the management of clinical trials.

Join us next month – June 16.

Attendees:
David Holland, Cmed Research
Jon Matheus, Pancrazi Real Estate
Sheila Mahoney-Jewels, Life Science Hub
Eric Nier, Block Clinical
Lynne Becker, Power of Patients
Nadia Bracken, Medidata
Christine Ver Straate, GLSA
Mitchell Efros, Verified Clinical Trials
Cassandra Hui, HealMary
Denise McNerney, GLSA
Joe Buser, GLSA
Tom Ryan, GLSA
Kalyan Ghosh, Inference Inc
Marty Frazier, GLSA
Tanusree Bhattacharyya, Inference Inc
Zulma Varela, GLSA
Mike O’gorman, Life Science Marketplace
David Gibboni, DJGibboni Consulting
Eric Mayer, EDP Biotech
Craig Fernandes, EDP Biotech
Maria Frane, C3 Research

FOCM Friendsgiving Wine Tasting Event

FOCM is all about connecting with each other for fun, mutual benefit and to be helpful to others.  On December 9, 2020 we held a virtual fundraiser, wine tasting and networking event.

FOCM values connections be they new or old. This event certainly crossed that spectrum. The idea for the event – wine, charity and networking – came about from a LinkedIn post that I saw from Amy Berwick. I first met Amy in 1998 when we both worked at Quintiles (nka IQVIA). Amy’s post had to do with the role she had taken on with OneHope Wines and I wanted to find out more and catch up with her. I knew I wanted to do a year end virtual FOCM networking event and thought this might be a fun option.

I met (virtually, of course) with Amy and her OneHope colleague, Shelby Wildgust and learned that in addition to 10% of the wine purchased supports the charity of my choosing, each individual bottle purchased supports a non-profit cause (e.g.; pet adoption, military veterans, reforestation…). I decided this is the event I wanted to have.

When they asked me what charity I’d like to support, I said the Jeffrey Coombs Memorial Foundation. http://www.jeffcoombsfund.org/blog/ This foundation was started by Christie Schmitt Coombs in memory of her husband who died in the 9/11 terrorist attack on America. The Jeff Coombs Foundation was formed to assist Massachusetts families who are in financial need because of a death, illness or other situation that challenges the family budget. I’ve known Christie for 45 years. We both grew up in Yuma, AZ, went to Kofa High School and the University of Arizona.

A screen shot from early in the event. Photography credit to Amy Matheus.

Attendees and in parentheses, how long I’ve known them were:
Deb Jendrasek (15 years), Shelby Wildgust (1 month), Jeff Gould (4 months), Michael D’Amico (3 months), Jon Matheus (his whole life), Zulma Varela (2 months) Christie Schmitt (45 years), Denise McNerney (6 months), Mike Strand (~15 years), Jenny Neurath (my whole life), Greg Cohee (~15 years), Susan Cook (2 years), Amy Berwick (22 years), Wayne and Kay (1 hour), Lauren Sherwood (3 years), Sean (1 hour) and Robin Whitsell (3 years), Amy Matheus (her whole life), Jamison Lloyd (2 years), Lindsay Goldman (her whole life), Nathan Goldman (9 years), Thomas Goldman (3 years), James Goldman (48 hours less than his whole life).

Amy and Shelby made it easy to manage. They drafted the email and messaging content for me to review, they set up the OneHope website specifically to track our fundraising progress and we used their zoom account. We tasted 3 different wines:
1. The Vintner Collection Sauvignon Blanc – this bottle helps reforestation, so far, ONEHOPE has been able to plant over 100,000 trees through the sale of this wine.   
2. The Vintner Collection Red Blend – this is a 96 point Award Winning wine that funds Team Rubicon, an organization aimed to reunite Veterans with a sense of purpose in civilian life.   
3. The Vintner Collection Pinot Noir – this is a 90 point Award Winning wine that has funded over 96,000 pet adoptions! 
Purchases made up until January 8 contribute toward the fundraising goal we’d set. Here is the event link to make purchases:   https://www.onehopewine.com/event/a366bd14-e43d-446e-94d9-6c44efeae9d9

Virtual FOCM Networking Events Review

During this Covid-19 Quarantine/Social Distancing, we’ve all seen an increase in the use of virtual meetings, virtual networking via videoconferencing tools.  Zoom, Hopin, GoogleMeet, FaceTime, Microsoft Teams, Free Conference Call are ones that I’ve been involved with to-date.

It is very interesting to hear how people are using these tools in a variety of clever ways. That’s the impressive nature of human-kind: creativity, innovation when circumstances impact us. 

I know of families having weekly Zoom calls to stay in touch. One includes playing a trivia game on each call, after catching up with everyone. Whoever wins the trivia game controls the questions for the next game. The Hopin (thanks GCPCafe and Nadia Bracken) tool has limits on the number of people who can be on camera at one time, while many more can participate via chat room to interact with the others.  This is good for interactive presentations by a few speakers. It also has a one-on-one video networking that I really enjoyed. You’re put into a “room” and are waiting for someone else to enter the “room” and then you see each other and start talking. It felt like meeting someone new at an industry conference reception without all the background noise and distractions.

I have held four FOCM virtual networking events using both Zoom and GoogleMeet. A friend said, ‘hey you’re the networking guy, you should be doing something during this time of isolation.’ I took it to heart and held events in the evenings on April 16, April 23, April 30 and May 13. Like I do when I would travel (remember that? – airplanes, hotels and rental cars?), I would email everyone I knew in the area to see who could meet up that night for drinks/dinner. So at first I held a FOCM event for the Philadelphia metro area, then for the Raleigh metro area, then the Boston metro area. It was about the April 30 Boston event, that I realized, I was no longer bound by geographic constraints. So the May 13 one was national (I did invite members from Europe, but it would have been 1 a.m. for them).

Attendance was taken, as per FOCM SOP:
April 16: Bryan Clayton, Dave Gibboni, Ryan Gibson, Chris McArthur, Chris McCracken, Pete Nieto, Mike Strand

April 23: Mike Burrows, Renee Brown, Brian Horan, Lauren Sherwood, Kate Mulllis (tried)- meeting minutes already published on www.focmnetworking.com/networking

April 30: Paul Bilden, Israel Bocanegra, Mike Burrows, Clint Craun, Scott Freedman, Brian Langin, Dan Weddle, Amy Zastawney
Observations: Two people had to exit early to attend other web calls, one for a birthday celebration – perhaps a glimpse of our future; night-time schedules of “virtual” meetings to stay in touch with friends, family and colleagues. I attended a friend’s birthday party on May 2 via Zoom.

May 13: 159 people were sent google calendar invitations, 111 never opened it (do that many people not receive google calendar invitations into their email inboxes?  24 said yes, 10 no and 14 maybe. There were some issues with people being able to talk and/or to see their faces.  We were on for an hour.  To manage it, we opened with a cheers! Then I called on people to share whatever they wanted on how they were coping or what they were learning. Using the chat feature I let the person who was up next know I’d be calling on them.  I know we didn’t get to everyone and I wish we had. It was great to see and hear from so many FOCM members.
Kevin Boos, Mike Burrows, Nadia Bracken, Renee Brown, Greg Cohee, Kevin Collier, Scott Freedman, Dave Gibboni, Heather Hollick, Askold Kozbur, Brian Langin, Jon Matheus, Chris McCracken, Lynne McKerlie, Karen McPoyle, Sarah Meister, Lorraine Mercer, Adrian Pencak, Roxann Pinguelo, Lauren Sherwood, Dan Weddle, Wayne Whittingham, Michael Williams.

Screen Grabs of the event were sent to me and they are shown below. The first one was sent to me with the subject line “ScreenGrab Tonight”. Proof that enjoyment of sarcasm and wit are fundamental to the FOCM code of behavior.

Screen Grab submitted by Dave Gibboni

I would like to hear of other interesting, unique, clever ways people are using these tools in this current time of reduced in-person gatherings. Use the comments box to share things you’re seeing or doing.

Screen Grab provided by Nadia Bracken
Screen Grab provided by Nadia Bracken
Dave Gibboni showing the Pixel by LabCorp self collection kit for Covid-19 testing